A microfluidic device was used in tandem with an imidazolium-based ionic liquid to fabricate monodisperse gold nanoparticles (4.38 ± 0.53 nm) with excellent control over size and morphology.
No takes yet. Share an insight, caveat, or question.
Lazarus et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: